Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (131-140 of 283) with videos related to

Pageof 29
Sort By:
Journal of Alzheimer'S Disease : JAD|October 30, 2016
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's DiseasePiotr Lewczuk, Anja Matzen, Kaj Blennow, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2019
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First BiomarkerFederico Massa, Lucia Farotti, Paolo Eusebi, et al.
Journal of Proteome Research|March 3, 2020
Fingerprinting Alzheimer's Disease by <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal FluidAlessia Vignoli, Silvia Paciotti, Leonardo Tenori, et al.
Plos One|May 17, 2014
Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI studyNicola Tambasco, Marco Muti, Pietro Chiarini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patientsLucilla Parnetti, Silvia Paciotti, Paolo Eusebi, et al.
Brain : a Journal of Neurology|July 11, 2024
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body diseaseLorenzo Barba, Samir Abu-Rumeileh, Henryk Barthel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 25, 2017
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderlyElena Chipi, Giulia Frattini, Paolo Eusebi, et al.
Frontiers in Neurology|January 31, 2022
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative DatabasesCinzia Costa, Elena Nardi Cesarini, Paolo Eusebi, et al.
Molecular Neurodegeneration|January 27, 2017
Therapeutic potential of autophagy-enhancing agents in Parkinson's diseaseTim E Moors, Jeroen J M Hoozemans, Angela Ingrassia, et al.
Journal of Parkinson'S Disease|April 14, 2020
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic StimulationSimone Simoni, Federico Paolini Paoletti, Paolo Eusebi, et al.
Pageof 29

Showing results (131-140 of 283) with videos related to

Sort By:
Pageof 29
Journal of Alzheimer'S Disease : JAD|October 30, 2016
Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer's DiseasePiotr Lewczuk, Anja Matzen, Kaj Blennow, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2019
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First BiomarkerFederico Massa, Lucia Farotti, Paolo Eusebi, et al.
Journal of Proteome Research|March 3, 2020
Fingerprinting Alzheimer's Disease by <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal FluidAlessia Vignoli, Silvia Paciotti, Leonardo Tenori, et al.
Plos One|May 17, 2014
Entacapone reduces cortical activation in Parkinson's disease with wearing-off: a f-MRI studyNicola Tambasco, Marco Muti, Pietro Chiarini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patientsLucilla Parnetti, Silvia Paciotti, Paolo Eusebi, et al.
Brain : a Journal of Neurology|July 11, 2024
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body diseaseLorenzo Barba, Samir Abu-Rumeileh, Henryk Barthel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 25, 2017
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderlyElena Chipi, Giulia Frattini, Paolo Eusebi, et al.
Frontiers in Neurology|January 31, 2022
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative DatabasesCinzia Costa, Elena Nardi Cesarini, Paolo Eusebi, et al.
Molecular Neurodegeneration|January 27, 2017
Therapeutic potential of autophagy-enhancing agents in Parkinson's diseaseTim E Moors, Jeroen J M Hoozemans, Angela Ingrassia, et al.
Journal of Parkinson'S Disease|April 14, 2020
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic StimulationSimone Simoni, Federico Paolini Paoletti, Paolo Eusebi, et al.
Pageof 29